Zimmer Biomet Holdings Inc (ZBH)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 525,500 | 569,000 | 420,100 | 393,000 | 415,800 | 292,100 | 319,800 | 330,200 | 375,700 | 545,400 | 386,400 | 435,800 | 378,100 | 919,600 | 1,042,400 | 724,300 | 802,100 | 967,300 | 713,400 | 2,433,600 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | 6,800 | 22,800 | 41,100 | — | 100,400 | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 2,450,900 | 3,571,300 | 3,608,400 | 2,797,000 | 2,857,400 | 2,071,500 | 2,233,700 | 2,335,900 | 2,358,200 | 2,295,700 | 2,463,600 | 2,674,100 | 3,467,900 | 2,939,100 | 2,928,500 | 2,089,400 | 2,556,900 | 2,266,200 | 2,161,200 | 3,779,600 |
| Cash ratio | 0.21 | 0.16 | 0.12 | 0.14 | 0.15 | 0.14 | 0.14 | 0.14 | 0.16 | 0.25 | 0.17 | 0.16 | 0.14 | 0.31 | 0.36 | 0.35 | 0.31 | 0.43 | 0.33 | 0.64 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($525,500K
+ $—K)
÷ $2,450,900K
= 0.21
The cash ratio of Zimmer Biomet Holdings Inc has fluctuated over the years based on the provided data. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents.
From March 31, 2020, to June 30, 2020, the cash ratio decreased from 0.64 to 0.33, indicating a significant reduction in the company's ability to cover its short-term liabilities with cash alone. However, there was a slight improvement in the ratio by September 30, 2020, at 0.43, showing a better liquidity position.
Subsequently, the cash ratio decreased to 0.31 by December 31, 2020, before gradually increasing to 0.36 by June 30, 2021. The ratio remained relatively stable for the next few quarters but experienced a decline to 0.14 by December 31, 2021, signaling a decrease in the company's ability to meet short-term obligations with readily available cash.
The cash ratio saw marginal improvements in the following quarters, reaching 0.25 by September 30, 2022. However, there was a decline to 0.14 by March 31, 2023, which continued through June 30, 2023. The ratio remained at 0.14 until December 31, 2023, before a slight increase to 0.15 by March 31, 2024.
Overall, the trend in the cash ratio of Zimmer Biomet Holdings Inc shows fluctuations, indicating varying levels of liquidity and the company's ability to meet short-term obligations with cash on hand over the reported periods.
Peer comparison
Dec 31, 2024